As of March 31, 2025, Doctrack Solutions Limited carries a market capitalization of 155.57M, placing it among publicly traded companies globally. Its enterprise value stands at 210.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 155.57M |
| Enterprise Value | 210.13M |
As of March 31, 2025, Doctrack Solutions Limited has 3.14M shares outstanding.
| Shares Outstanding | 3.14M |
These figures are as of March 31, 2025.
| PB Ratio | 1.86 |
| P/TBV Ratio | -4.78 |
As of March 31, 2025, Doctrack Solutions Limited maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.85 |
| Quick Ratio | 0.07 |
| Debt / Equity | 88.38 |
These figures cover the twelve months ended March 31, 2025.
| Employee Count | 58.00 |
As of the close on October 22, 2026, Doctrack Solutions Limited's stock has declined approximately 80.89% over the past 52 weeks. The 50-day moving average sits at 32.10, while the 200-day moving average is 59.16.
| 52-Week Price Change | -80.89% |
| 50-Day Moving Average | 32.10 |
| 200-Day Moving Average | 59.16 |
As of March 31, 2025, Doctrack Solutions Limited holds 19.22M in cash and equivalents against 73.78M in total debt, resulting in a net debt position of 55.43M. Total book value stands at 83.48M, with working capital of -42.61M providing operational flexibility.
| Cash & Cash Equivalents | 19.22M |
| Total Debt | 73.78M |
| Net Debt | 55.43M |
| Equity (Book Value) | 83.48M |
| Book Value Per Share | 26.56 |
| Working Capital | -42.61M |
Already premium?